obesity drug news today glp-1 2025 Use of diabetes and anti-obesity drugs surges nationwide GLP-1 Receptor Agonists Obesity Drugs

Causal factors for knee, hip, and hand osteoarthritis: a Mendelian randomization study in the UK biobank

Dark Circles That Don't Respond to Topical Treatment Dark circles have multiple causes, but oxidative stress and poor cellular repair are among the most common

Peptides are essentially miniature proteins, says John Fetse, a peptide therapeutics researcher at Binghamton University in New York

Clinical data indicate that as many as half of all patients who use GLP-1s stop using them within a year

The compounded methylene blue anti-aging cream uses 0.0064 percent methylene blue, well below the approximately 0.05 percent threshold at which visible blue staining occurs on skin